Gaudium IVF & Women Health Subscription
Last updated on 20-Feb-2026 19:59:06
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 4177240 | 2646 | 0 |
| HNIs | 3132930 | 2851821 | 0.91 |
| HNIs 10+ | 2088620 | 1129464 | 0.54 |
| HNIs 2+ | 1044310 | 1722357 | 1.65 |
| Retail | 7310170 | 10423161 | 1.43 |
| Total | 14620340 | 13277628 | 0.91 |
Application-Wise Breakup (Approx. no. of Apps) | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 789 | 86 | 0.11 |
| HNIs (2-10L) | 395 | 593 | 1.5 |
| Retail | 38678 | 42483 | 1.1 |
| Total Applications: 43162 | |||
| © IPO Premium | |||
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIBs | 33 | 0.02 | 0 |
| FIIs | - | 0 | - |
| DIIs | - | 0 | - |
| Mutual funds | - | 0 | - |
| Others | - | 0.02 | - |
| HNIs | 24.75 | 22.53 | 0.91 |
| HNIs 10+ | 16.5 | 8.92 | 0.54 |
| HNIs 2+ | 8.25 | 13.61 | 1.65 |
| Retail | 57.75 | 82.34 | 1.43 |
| Total | 115.5 | 104.89 | 0.91 |
Gaudium IVF & Women Health Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 189 | 14931 | 38678 |
| sHNI | 14 | 2646 | 209034 | 395 |
| bHNI | 67 | 12663 | 1000377 | 789 |
Gaudium IVF & Women Health Reservation
| Category | Shares Offered | % |
|---|---|---|
| Anchor | 6265860 | 30% |
| QIB | 4177240 | 20% |
| HNI | 3132930 | 15% |
| Retail | 7310170 | 35% |
| Total | 20886200 | 100% |
Gaudium IVF & Women Health About
IPO Details
| Total Issue Size | 2,08,86,200 shares (aggregating up to ₹165.00 Cr) |
| Fresh Issue | 1,13,92,500 shares (aggregating up to ₹90.00 Cr) |
| Offer For Sale | 94,93,700 shares (aggregating up to ₹75.00 Cr) |
| Face Value | ₹5/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE,BSE |
| Share Holding Pre Issue | 6,13,94,384 shares |
| Share Holding Post Issue | 7,27,86,884 shares |
Key Performance Indicators (KPI)
| KPI | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| ROE | 21.25% | 41.31% | 38.23% | 59.51% |
| ROCE | 21.03% | 39.37% | 38.74% | 54.40% |
| EPS (BASIC) | 2.04 | 3.12 | 1.68 | 2.20 |
| P/E Pre IPO | 25.36 | |||
| P/E Post IPO | 22.99 |
Company Financial (In ₹Crore)
| Period Ended | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| NET Worth | 58.85 | 46.3 | 26.99 | 22.73 |
| Reserves and Surplus | 28.16 | 15.6 | 26 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Peer Comparison (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value *(₹) |
|---|---|---|---|
| Gaudium IVF and Women Health Limited | 25.36 | 79.00 | 5.00 |
| Progyny Inc | 41.56 | 2099.98 | $0.0001 |
| Inspire IVF Public Company Limited | 11.43 | 1.99 | THB 0.05 |
Peer Comparison (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Gaudium IVF and Women Health Limited | 7.54 | 41.71 | 3.12 |
| Progyny Inc | 394.20 | 12.90 | 50.52 |
| Inspire IVF Public Company Limited | 4.34 | 3.97 | 0.17 |
About Company
Incorporated in March 2015, Gaudium IVF and Women Health Limited is engaged in providing In Vitro Fertilization (IVF) and women’s healthcare services across India through a hub-and-spoke model.
The company operates over 30 locations, including 7 hub centres and 28 spoke centres, expanding its reach through a strategic alliance with infertility experts to promote awareness of ART and IVF treatments.
It caters to both domestic and international patients from countries such as Canada, the UK, the USA, Kenya, South Africa, and Oman.
Centres are located in key cities including Delhi (Janakpuri & Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore.
The company offers specialized fertility services such as IVF, ICSI, IUI, ovulation induction, egg freezing, laser-assisted embryo implantation, along with treatment for PCOD/PCOS, endometriosis, high-risk pregnancy management, and advanced male infertility procedures.
Facilities are equipped with next-generation INTEGRA Ti labs for advanced ICSI procedures.
Strength
Patient-Centric Pricing Approach: The Company adopts package-based treatments, bundled services, and installment schemes to make fertility care affordable for middle-income groups. Transparent pricing and flexible financing options enhance patient trust and expand the customer base.
Strong Brand Positioning & Trust Creation: The Company focuses on awareness campaigns, patient education, and testimonials to reduce stigma and strengthen its brand credibility. Accreditation from recognized medical associations and adherence to ethical practices further enhance reputation and reliability.
Focus on Medical Tourism: Leveraging India’s cost advantage, the Company attracts international patients through multilingual support, concierge services, and global collaborations. Strategic tie-ups with overseas agencies and hospitals support a steady inflow of foreign patients.
Weakness
Operational & Medical Risks in Fertility Services: The Company operates in fertility treatments such as IVF, IUI, ICSI, and egg freezing, which involve medical, operational, legal, and reputational risks. Any failure to maintain quality healthcare standards could adversely affect its reputation, business prospects, and financial performance.
Related Party Transactions & Potential Conflicts: The Company has entered into and may continue to enter into related party transactions, including loans, advances, and guarantees. Such arrangements may give rise to potential conflicts of interest.
Dependence on Limited Embryologists: The Company’s operations across seven centers rely heavily on five embryologists. Any inability to retain or attract qualified embryologists could adversely impact operations, financial condition, and growth.
Gaudium IVF & Women Health Lead Manager(s)
Gaudium IVF & Women Health Address
Address
B1/51,
Janak Puri,
B-1,New Delhi, New Delhi, 110058
011-4885 8585
E-Mail: compliance@gaudiumivfcentre.com
Website:https://www.gaudiumivfcentre.com/
Gaudium IVF & Women Health Registrar
Gaudium IVF & Women Health Reviewers
| Reviewer | Recommendation | File |
|---|---|---|
| Kunvarji Finstock Pvt Ltd | Apply | |
| DRChoksey Finserv Private Limited | Apply | |
| Arihant Capital Markets Ltd | Apply | |
| BP Equities (BP Wealth) | Apply | |
| SMIFS Limited | Apply | |
| Swastika Investmart Ltd | Apply | |
| Ventura Securities Limited | Apply | |
| Capital Market | May Apply |